9:22 AM
Leo Group India
| ||
| Astex Pharmaceuticals in drug discovery pact with Cancer Research Technology ... domain-B Astex Pharmaceuticals, Inc, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, Cancer Research Technology Limited (CRT) and Newcastle University have signed a major five-year strategic drug ... See all stories on this topic » | ||
| Switzerland's Lonza axes 500 jobs to cut costs Reuters India The cuts at the Basel-based firm, which makes pharmaceutical ingredients for drugmakers such as GlaxoSmithKline and Abbott, equate to around 5 percent of its global workforce of about 11,000. In its third-quarter business update on Wednesday, Lonza ... See all stories on this topic » | ||
| Catalyst Pharmaceutical Partners and BioMarin Pharmaceutical Enter Into ... NASDAQ CORAL GABLES, Fla., Oct. 31, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) and BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that they have entered into a strategic collaboration for the rights to ... See all stories on this topic » | ||
| Patheon enters pact with Vion to acquire specialty pharma co, Banner Pharmacaps pharmabiz.com Patheon Inc. a leading provider of contract development and manufacturing services to the global pharmaceutical industry, has entered into a definitive agreement with Netherlands-based foodstuffs and ingredients manufacturer, Vion N.V., to acquire ... See all stories on this topic » | ||
| DGAP-News: Astex Pharmaceuticals to Present at EORTC-NCI-AACR Equities.com DGAP Astex Pharmaceuticals, Inc. 31.10.2012 11:00 --------------------------------------------------------------------------- DUBLIN, Calif., 2012-10-31 11:00 CET (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company ... See all stories on this topic » | ||
| Novartis to start construction of new biotechnology facility in Singapore with ... Reuters Investment supports growing pipeline of biologics portfolio representing 25% of current clinical pharmaceutical research pipeline; Singapore will operate as a technological competence center for biotechnology and pharmaceutical production; Construction ... See all stories on this topic » | ||
| Global High Potency Active Pharmaceutical Ingredients (HPAPIs) Market is ... Sacramento Bee India and China will be the major countries to register high growth rate in the high potency active pharmaceutical ingredients (HPAPIs) market due to rising health awareness, growing economies and improving healthcare systems. Browse the full report at ... See all stories on this topic » | ||
| Administering two new pharmaceutical drugs to combat hepatitis C increases ... Basque Research Administering two new pharmaceutical drugs - Telaprevir and Boceprevir -, together with those currently used to date - interferon and ribavirine -, enables increasing the cure rate of hepatitis C patients from 45% to 75% on average, according to Doctor ... See all stories on this topic » | ||
| May not see 35% growth in H1 sustaining in H2 Moneycontrol.com We are growing in excess of 15 percent ahead of the overall Indian pharmaceutical industry. This is all on account of a restructuring exercise that we did last year where we increased the field force, we restructured the product mix. We increased the ... See all stories on this topic » | ||
| TAKEDA PHARMACEUTICAL COMPANY LIMITED : Millennium and Takeda ... 4-traders Millennium: The Takeda Oncology Company and Takeda Pharmaceutical Company Limited (TSE:4502, "Takeda"), today announced that the European Commission (EC) has granted conditional marketing authorization for ADCETRIS® (brentuximab vedotin) ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment